Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care

被引：3
|
作者：
Madan, Ravi A. [1 ]
Yu, Evan Y. [2 ,3 ]
Posadas, Edwin M. [4 ]
Lee, Richard J. [5 ]
Karzai, Fatima [1 ]
Choyke, Peter L. [6 ]
机构：
[1] NCI, Genitourinary Malignancies Branch, Bethesda, MD 20814 USA
[2] Univ Washington, Seattle, WA USA
[3] Fred Hutchinson Canc Ctr, Seattle, WA USA
[4] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med, Boston, MA USA
[6] NCI, Mol Imaging Branch, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 19期
关键词：
D O I：
10.1200/JCO.23.02727
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
#PSMA is amazing new tech but is using it to expedite the call of disease progression helping #ProstateCancer patients?
引用
收藏
页数：4
相关论文
共 50 条
  • [31] The change in expression of prostate-specific membrane antigen in circulating tumor cells during treatments for castration-resistant prostate cancer
    Nagaya, N.
    Kanayama, M.
    Nagata, M.
    Horie, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Expression of prostate-specific membrane antigen (PSMA) on circulating tumor cells (CTCs) in castration-resistant prostate cancer.
    Lee, Florence
    Yu, Angela
    Anderson, Amanda
    Marrinucci, Dena
    Magargal, Wells W.
    DiPippo, Vincent A.
    Olson, William C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] Re: Prostate-specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-resistant Prostate Cancer
    Walz, Jochen
    EUROPEAN UROLOGY, 2020, 78 (02) : 292 - 293
  • [34] Our initial experience with Lu-177 PSMA (Pluvicto) for Metastatic prostate-specific membrane antigen-aε"-positive metastatic castration-resistant prostate cancer
    Cardenas, Karol
    Atcheson, Kyle
    Bradley, Yong
    Benayoun, Marc
    Cengiz, Turgut Bora
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [35] 177Lu-Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer
    Parihar, Ashwin Singh
    Hofman, Michael S.
    Iravani, Amir
    RADIOLOGY, 2023, 306 (02)
  • [36] Noninvasive measurement of prostate-specific membrane antigen (PSMA) expression with radiolabeled J591 imaging: A prognostic tool for metastatic castration-resistant prostate cancer (CRPC)
    Tagawa, Scott T.
    Akhtar, Naveed Hassan
    Christos, Paul J.
    Osborne, Joseph
    Vallabhajosula, Shankar
    Freedy, Shoaib
    Goldsmith, Stanley J.
    Nanus, David M.
    Bander, Neil Harrison
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics
    Brady-Nicholls, Renee
    Zhang, Jingsong
    Zhang, Tian
    Wang, Andrew Z.
    Butler, Robert
    Gatenby, Robert A.
    Enderling, Heiko
    NEOPLASIA, 2021, 23 (09): : 851 - 858
  • [38] Comment on: "Modeling the Relationship between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer''
    Srinivas, Nuggehally R.
    CLINICAL PHARMACOKINETICS, 2017, 56 (02) : 211 - 212
  • [39] Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA
    Carrot, Aurore
    Oudard, Stephane
    Colomban, Olivier
    Fizazi, Karim
    Maillet, Denis
    Sartor, Oliver
    Freyer, Gilles
    You, Benoit
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [40] Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment
    Attard, Gerhardt
    Borre, Michael
    Gurney, Howard
    Loriot, Yohann
    Andresen-Daniil, Corina
    Kalleda, Ranjith
    Trinh Pham
    Taplin, Mary-Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (25) : 2639 - +
12345